Locky
Manganese X (Canada) released some processing costs numbers on Friday. Check them against your estimates to see if you are on track...
- Pit optimization parameters include: pricing of US$1500/tonne for High Purity Manganese Sulphate Monohydrate – 32% Mn,
- exchange rate of CDN $1.30 to US$ 1.00,
- mining at CDN $6.50/t, combined processing and G&A (1000 tpd) at CDN $86.22/t processed and a process recovery of Mn to HPMSM of 65%.
- Fe content was not included in the pit optimization. Mineral resources are reported at a cut-off grade of 2.50 % Mn within the optimized pit shell. This cut-off grade reflects total operating costs used in pit optimization to define reasonable prospects for eventual economic extraction by open pit mining methods.Mineral resources were estimated using Ordinary Kriging methods applied to 3 m downhole assay composites. No grade capping was applied. Model block size is 5 m (x) by 5 m (y) by 5 m (z)Bulk density was applied using a regression curve based on Mn % and Fe % block grades.
- Forums
- ASX - By Stock
- E25
- 99.95% High Purity Manganese
99.95% High Purity Manganese, page-47
-
-
- There are more pages in this discussion • 908 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add E25 (ASX) to my watchlist
(20min delay)
|
|||||
Last
26.5¢ |
Change
0.010(3.92%) |
Mkt cap ! $58.27M |
Open | High | Low | Value | Volume |
25.5¢ | 27.5¢ | 25.5¢ | $14.61K | 56.46K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 11195 | 26.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
28.0¢ | 16500 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 11195 | 0.265 |
3 | 22582 | 0.260 |
5 | 151669 | 0.255 |
2 | 10000 | 0.250 |
2 | 140000 | 0.245 |
Price($) | Vol. | No. |
---|---|---|
0.280 | 16500 | 2 |
0.285 | 91666 | 2 |
0.295 | 1694 | 1 |
0.300 | 49203 | 3 |
0.310 | 166513 | 5 |
Last trade - 15.48pm 13/11/2024 (20 minute delay) ? |
Featured News
E25 (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online